Weather | Traffic | Surf | Maps | Webcam


   
 
Forums Visitors Guide Shopping Classifieds Autos Homes Jobs Entertainment Sports Today's Paper Home

 News
 Metro | Latest News
 North County
 Temecula/Riverside
 Tijuana/Border
 California
 Nation
 Mexico
 World
 Obituaries
 Today's Paper
 AP Headlines
 Business
 Technology
 Biotech
 Markets
 In Depth
 Iraq / Afghanistan
 Pension Crisis
 Special Reports
 Video
 Multimedia
 Photo Galleries
 Topics
 Education
 Features
 Health | Fitness
 Military
 Politics
 Science
 Solutions
 Opinion
 Columnists
 Steve Breen
 Forums
 Weblogs
 Communities
 U-T South County
 U-T East County
 Solutions
 Calendar
 Just Fix It
 Services
 Weather
 Traffic
 Surf Report
 Archives
 E-mail Newsletters
 Wireless | RSS
 Noticias en Enlace
 Internet Access
 Sponsored Links
More World news
Canada scraps medical reactor plan, says isotopes safe

REUTERS

7:10 a.m. May 16, 2008

OTTAWA – Canada said Friday it was scrapping work on a trouble-plagued nuclear reactor project designed to produce medical radioisotopes, but promised to maintain output by continuing to use an older reactor.

Atomic Energy of Canada Limited (AECL) said it was halting work on the two small reactors that make up its proposed MAPLE project because of the expense and the problems experienced.

The 50-year-old National Research Universal (NRU) reactor at the Chalk River facility in eastern Ontario will remain operational, producing the isotopes that are used in medical tests around the world.

Chalk River produces medical isotopes for Canadian health care company MDS Inc and its MDS Nordion division, which is responsible for about half of world supply.

“The decision to discontinue development of the MAPLE reactors will not impact the current supply of medical isotopes as commercial agreements between MDS Nordion and AECL provide for isotope production to continue through (the) NRU and associated facilities in Chalk River,” said AECL.

A shut-down of the NRU reactor late last year caused a shortage of radioisotopes, which are used in cancer tests.

The NRU has a license to operate until Oct. 31, 2011. The government said had asked AECL “to pursue an extension of the NRU operation beyond its current license to ensure the ongoing supply of medical isotopes”.

When injected into the body, the isotopes give off radiation that can be seen by a camera to diagnose cancer, heart disease and other medical conditions. They have a very short shelf-life and cannot be stockpiled.

The two MAPLE reactors – which have cost more than C$500 million ($500 million) to develop – were originally supposed to come on line in 2000.

The decision to scrap the project came as little surprise, since experts have long pointed to what they say are the project's serious design flaws.

“These reactors have never worked and never produced medical isotopes ... the project has long been crippled with both technical and economic impediments, which remained unresolved,” the government said in a statement.

Ottawa said the reactors had failed every one in a series of tests carried out last month.

The government fired the country's main nuclear watchdog in January, saying she had mishandled the affair.

Canadian Nuclear Safety Commissioner Linda Keen had refused to allow the NRU to restart after regular maintenance in November, saying not enough safety systems were working.

MDS Nordion did not immediately return a call seeking comment.

($1-$1 Canadian)

(Reporting by David Ljunggren; editing by Janet Guttsman)


 Sponsored Links







Quicklinks
Restaurants Bars
Hotels Autos
Shopping Health
Eldercare Singles
Business Listings
Free Newsletters


Guides
Vegas Spas/Salon
Travel Weddings
Wine Old Town
Baja Catering
Casino Home Imp.
Golf SD North
Gaslamp


© Copyright 1995-2008 Union-Tribune Publishing Co. • A Copley Newspaper Site